AstraZeneca (coronavirus vaccine candidate) update – firm spends $60m to ensure production capacity

COVID-19 – some news from a couple of days ago, so its not ‘breaking’, just an update.

  • British drugmaker AstraZeneca to secure capacity to meet what could be a 3 billion-dose demand for its vaccine, AZD1222
  • will pay Oxford Biomedica an initial $20 million to reserve production capacity for at least 18 months
COVID-19 - some news from a couple of days ago, so its not 'breaking', just an update.
Go to top